Noninferiority of Denosumab As Compared With Zolendronic Acid With Respect to the Ability to Delay Skeletal Events in Patients With Solid Tumors and Multiple Myeloma
08:11
Share
2011/3/17
Journal of Clinical Oncology (JCO) Podcast
Request Transcript
Frequently requested episodes will be transcribed first
Shownotes
Transcript
No transcript made for this episode yet, you may request it for free.